Lukasz Skalniak

23PUBLICATIONS
59CO-AUTHORS
Nanofabrication, growth and self assemblyProteins and peptidesMolecular targetsMolecular medicineBiomolecular modelling and design
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|Feb 23, 2026
Coupling PD-L1 Inhibition and Lysosomal Degradation: Innovative Anti-PD-L1 Peptides for NSCLC Immunotherapy.

Francesco Merlino, Valentina Pagliara, Vincenzo Maria D'Amore

|Jul 16, 2025
Characterization of Clinically Evaluated Small-Molecule Inhibitors of PD-L1 for Immunotherapy.

Alicja Slota, Katarzyna Golebiowska-Mendroch, Justyna Kocik-Krol

|May 07, 2025
Correction: Musielak et al. CA-170 - A Potent Small-Molecule PD-L1 Inhibitor or Not? Molecules 2019, 24, 2804.

Bogdan Musielak, Justyna Kocik, Lukasz Skalniak

|Jun 21, 2024
An updated patent review on PD-1/PD-L1 antagonists (2022-present).

Wiktor Uzar, Beata Kaminska, Hubert Rybka

Pageof 4